EUCTR2005-006041-16-GB进行中（未招募）1 期
Double-blind follow on study of pitavastatin (4 mg)versus atorvastatin (20 and 40 mg), with a single-blind extension of treatment, in patients with type II diabetes mellitus and combined dyslipidemia
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •All patients entering this study must have satisfied inclusion/exclusion criteria for the previous core study (NK-104-305, EudraCT number 2005-001038-34). As participants in Study NK 104 305, patients have previously received pitavastatin (at 2 mg up-titrated to 4 mg QD after 4 weeks) or a comparator (atorvastatin 10 mg up-titrated to 20 mg QD after 4 weeks) for a total of 12 weeks and followed a diet according to EAS guidelines (Appendix A) for 18 to 20 weeks. To be eligible for participation in this study the patients must have completed 12 weeks of active treatment in the core study (NK-104-305) and continue to follow the diet according to EAS guidelines.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •All patients entering this study must have satisfied inclusion/exclusion criteria for the previous core study (NK-104-305).
研究者
相似试验
已完成
3 期
Double-blind follow-on study of Pitavastatin (4 mg) versus Simvastatin (40 mg and 80 mg), with a single-blind extension of treatment, in patients with Primary Hypercholesterolemia or Combined Dyslipidemia and 2 or more risk factors for Coronary Heart DiseaseNL-OMON30052Kowa Research Europe50
已完成
3 期
Double-Blind follow-on study of Pitavastatine (4mg)versus atorvastatine (20 mg and 40 mg), with a single extension of treatment in patients with type II Diabetes Mellitus and Combined DyslipidemiaNL-OMON30046Kowa Research Europe50
已完成
3 期
Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined DyslipidemiaType II Diabetes MellitusDyslipidemiaNCT00344370Kowa Research Europe214
已完成
3 期
Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk FactorsHypercholesterolemiaCoronary Heart DiseaseDyslipidemiaNCT00344175Kowa Research Europe178
已完成
4 期
Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed DyslipidemiaPrimary DyslipidemiaMixed DyslipidemiaNCT01256476Kowa Research Institute, Inc.328